AGENUS INC Treasury Stock, Shares
AGENUS INC (AGEN) had Treasury Stock, Shares of 3.07 thousand shares as of 2016-06-30, per its 10-Q filed 2016-08-04.
Discontinued › Notes
us-gaap:TreasuryStockShares · last filed 2016-08-04
- 2016-06-30: Treasury Stock, Shares 3.07K shares.
- 2015-06-30: Treasury Stock, Shares 0.00 shares.
- 2015-03-31: Treasury Stock, Shares 0.00 shares.
- 2014-12-31: Treasury Stock, Shares 0.00 shares.
| Period end | Treasury Stock, Shares | Treasury Stock, Shares as first filed |
|---|---|---|
| 2016-06-30 | 3.07K shares 10-Q · filed 2016-08-04 | |
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-03 | |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-01 | |
| 2014-12-31 | 0.00 shares 10-Q · filed 2015-08-03 | |
| 2014-09-30 | 0.00 shares 10-Q · filed 2014-10-31 | |
| 2014-06-30 | 0.00 shares 10-Q · filed 2014-08-01 | |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-09 | |
| 2013-12-31 | 43.49K shares 10-K · filed 2015-03-16 | |
| 2013-09-30 | 43.49K shares 10-Q · filed 2013-11-08 | |
| 2013-06-30 | 43.49K shares 10-Q · filed 2013-08-09 | |
| 2013-03-31 | 43.49K shares 10-Q · filed 2013-05-10 | |
| 2012-12-31 | 43.49K shares 10-K · filed 2014-03-07 | |
| 2012-09-30 | 43.49K shares 10-Q · filed 2012-11-07 | |
| 2012-06-30 | 43.49K shares 10-Q · filed 2012-08-08 | |
| 2012-03-31 | 43.49K shares 10-Q · filed 2012-05-09 | |
| 2011-12-31 | 43.49K shares 10-K · filed 2013-03-18 | |
| 2011-09-30 | 43.49K shares 10-Q · filed 2011-11-04 | |
| 2011-06-30 | 260.94K shares 10-Q · filed 2011-08-05 | |
| 2010-12-31 | 43.49K shares 10-K · filed 2012-03-06 | 260.94K shares 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |